APTINYX INC (APTX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:APTX • US03836N1037

0.061 USD
-0.04 (-39%)
At close: May 18, 2023
0.074 USD
+0.01 (+21.31%)
After Hours: 5/18/2023, 8:22:26 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall APTX gets a fundamental rating of 2 out of 10. We evaluated APTX against 523 industry peers in the Biotechnology industry. APTX has a bad profitability rating. Also its financial health evaluation is rather negative. APTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year APTX has reported negative net income.
  • In the past year APTX has reported a negative cash flow from operations.
APTX Yearly Net Income VS EBIT VS OCF VS FCFAPTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

  • APTX has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APTX Yearly ROA, ROE, ROICAPTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for APTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APTX Yearly Profit, Operating, Gross MarginsAPTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • APTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, APTX has about the same amount of shares outstanding.
  • The debt/assets ratio for APTX is higher compared to a year ago.
APTX Yearly Shares OutstandingAPTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
APTX Yearly Total Debt VS Total AssetsAPTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

  • APTX has an Altman-Z score of -9.38. This is a bad value and indicates that APTX is not financially healthy and even has some risk of bankruptcy.
  • APTX has a Altman-Z score of -9.38. This is in the lower half of the industry: APTX underperforms 75.87% of its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that APTX is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.58, APTX is doing worse than 75.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z -9.38
ROIC/WACCN/A
WACC6.92%
APTX Yearly LT Debt VS Equity VS FCFAPTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 10.18 indicates that APTX has no problem at all paying its short term obligations.
  • APTX's Current ratio of 10.18 is fine compared to the rest of the industry. APTX outperforms 75.71% of its industry peers.
  • APTX has a Quick Ratio of 10.18. This indicates that APTX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 10.18, APTX is in the better half of the industry, outperforming 75.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.18
Quick Ratio 10.18
APTX Yearly Current Assets VS Current LiabilitesAPTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 13.51% over the past year.
  • The Revenue for APTX has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)13.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.93%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • APTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.76% yearly.
  • The Revenue is expected to grow by 204.67% on average over the next years. This is a very strong growth
EPS Next Y50.06%
EPS Next 2Y23.79%
EPS Next 3Y15.29%
EPS Next 5Y8.76%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y204.67%

3.3 Evolution

APTX Yearly Revenue VS EstimatesAPTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2027 2028 2029 2030 100M 200M 300M
APTX Yearly EPS VS EstimatesAPTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for APTX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APTX Price Earnings VS Forward Price EarningsAPTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APTX Per share dataAPTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • APTX's earnings are expected to grow with 15.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.79%
EPS Next 3Y15.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • APTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

APTINYX INC

NASDAQ:APTX (5/18/2023, 8:22:26 PM)

After market: 0.074 +0.01 (+21.31%)

0.061

-0.04 (-39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-17
Earnings (Next)08-02
Inst Owners0%
Inst Owner Change0%
Ins Owners7.7%
Ins Owner Change0%
Market Cap4.13M
Revenue(TTM)N/A
Net Income(TTM)-64.85M
Analysts47.5
Price Target0.51 (736.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.38%
Min EPS beat(2)6.44%
Max EPS beat(2)8.33%
EPS beat(4)4
Avg EPS beat(4)7.6%
Min EPS beat(4)6.4%
Max EPS beat(4)9.25%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)29.82%
EPS NY rev (1m)0%
EPS NY rev (3m)35.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.11
P/tB 0.11
EV/EBITDA N/A
EPS(TTM)-0.96
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS0
BVpS0.57
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.18
Quick Ratio 10.18
Altman-Z -9.38
F-ScoreN/A
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.93%
EPS Next Y50.06%
EPS Next 2Y23.79%
EPS Next 3Y15.29%
EPS Next 5Y8.76%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y204.67%
EBIT growth 1Y16.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-3.82%
EBIT Next 3Y78.71%
EBIT Next 5Y60%
FCF growth 1Y5.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.9%
OCF growth 3YN/A
OCF growth 5YN/A

APTINYX INC / APTX FAQ

What is the ChartMill fundamental rating of APTINYX INC (APTX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to APTX.


What is the valuation status for APTX stock?

ChartMill assigns a valuation rating of 3 / 10 to APTINYX INC (APTX). This can be considered as Overvalued.


What is the profitability of APTX stock?

APTINYX INC (APTX) has a profitability rating of 0 / 10.


How financially healthy is APTINYX INC?

The financial health rating of APTINYX INC (APTX) is 4 / 10.


What is the expected EPS growth for APTINYX INC (APTX) stock?

The Earnings per Share (EPS) of APTINYX INC (APTX) is expected to grow by 50.06% in the next year.